ISB News

ISB Gets $2.3 million NIH Grant to Use Single-Cell Technology to Fight Cancer

Pictured above: Dr. Qiang Tian, left, and Dr. Edward Lin, right, discuss single-cell analysis technologies developed at Institute for Systems Biology in Seattle.

September 22, 2014 – ISB has received a $2.3 million NIH grant over four years in response to NCI’s “Provocative Questions” Initiative. The project will apply ISB’s most advanced single-cell omics technologies to an innovative clinical trial for colorectal cancer (ADAPT). Principal investigator Qiang Tian, MD, PhD, head of the Cancer & Stem Cell Group, explained that the goal is to identify single cell signatures that can be used to stratify those patients who respond well to the treatment from those who are resistant to the treatment. For the patients who do not respond, the hope is to figure out a better treatment scheme from the study.

A comment from one of the proposal reviewers stated: “Using clinical trial-treated tumors to characterize the sub-grouping could lead to changes in future regimens and will provide a wealth of translational knowledge. (This) will answer questions about cellular resistance which has many implications on treatment regimens. This potentially can have broad ranging implications in understanding tumor resistance, how treatment fails and future chemotherapy regimens, all of which would be highly significant.”

ISB is collaborating on this research with Dr. Edward Lin, a medical oncologist at Seattle Cancer Care Alliance, associate member of Fred Hutchinson Cancer Research Center, and associate professor at the University of Washington. Dr. Lin was named 2014 Cancer Researcher of the Year by The Gateway For Cancer Research organization.

Acknowledgment: This research is supported by the National Cancer Institute of the National Institutes of Health under Award Number R01CA190122. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The ADAPT trial is funded by The Gateway for Cancer Research.

 

Recent Articles

  • Ilya Shmulevich

    ‘A Life Like No Other:’ Remembering Beloved ISB Professor Ilya Shmulevich

    Devoted husband and father. Animal lover. Accomplished pianist. Avid cyclist. Compassionate human. Exceptional scientist. The ISB community mourns the loss of Professor Ilya Shmulevich, PhD, who died on April 13, 2024. He was 54 years old.

  • ISB-Town Hall Seattle Event: Hack Your Health

    Please join us at Town Hall Seattle on Thursday, June 13 at 7:30 p.m. for a fun, informative conversation between “Hack Your Health” director Anjali Nayar and ISB Associate Professor Dr. Sean Gibbons, who will discuss the making of the Netflix documentary, interesting developments in microbiome research, and much more.

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In May, the ISB Education team hosted student visitors from Lincoln High School, dozens of science education leaders who run projects in Washington state’s ClimeTime program, and more.